Navigation Links
Clazosentan May help to Improve Blood Circulation after Brain Hemorrhage due to burst Aneurysm

A study published in the July edition of the Journal of Neurosurgery suggests that Clazosentan can reduce the // number and severity of cases of constriction of blood vessels (called vasospasm) following aneurysmal subarachnoid haemorrhage (SAH).

Normally constriction of blood vessels occurs approx. 5-14 days following a SAH and this leads to strokes and neurological deficits. This can cause not only significant disability but is also a major cause of death.

Patients on the drug also develop fewer cerebral infarcts. Dr Peter Vajkoczy, Neurosurgeon at the Department of Neurosurgery, University Hospital, Mannheim, and the main author of the study comments: "While our understanding of cerebral vasospasm has continued to improve, a solution to this challenge is yet to be found. However, these results are certainly promising and it is important that these findings are assessed and confirmed in a larger population to identify how clazosentan may have an impact in clinical practice."

Dr Neal Kassell, Professor and Co-chairman of the Department of Neurological Surgery at the University of Virginia comments: "It is encouraging to finally, after nearly one-half century of futile investigations, be able to introduce into clinical trials an agent that, based on experimental studies, has a real potential for preventing vasospasm and, based on preliminary clinical studies, appears to be without significant side effects (including hypotension), as well as exhibiting a suggestion of efficacy."

Over a quarter of people die within the first week following an aneurysmal subarachnoid haemorrhage without treatment. Re-bleeding occurs in 50% of the aneurysms within the first six months, and about half of patients die after a rebleed and a further 20% become disabled.

For further info contact: Actelion contact: Alan Archer Global Product Communications manager Actelion Ltd Gewerbestrasse 16 CH-4123 Allschwil Switz erland 41-79-289-8083

Related medicine news :

1. Hypertensive Drug Improves Sexual Dysfunction in Hypertensive Men
2. Steps To Improve Quality Of Plant-Based Drugs
3. Almonds Improve Cholesterol
4. How to Improve Life Expectancy
5. Sage Improves Memory
6. Protein said to Improve Muscle Loss
7. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
8. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
9. Vitamin B12 Supplements Found To Improve Memory
10. A Loving Relationship Found To Improve Heart Health
11. Fish Found To Improve Fetal Growth
Post Your Comments:

(Date:10/13/2015)... ... 13, 2015 , ... SPH Analytics today announced the following ... Executive Vice President of Operations, and three Senior Vice Presidents, Robert Davis, David ... company. , Debbie Vereb’s appointment to Executive Vice President of Operations at SPH ...
(Date:10/13/2015)... ... 2015 , ... Curly Hair Solutions® is thrilled to be ... exhibition featuring the newest products and services to hit the market for women. ... excited to unveil their recent partnership with Trade Secrets, a leading Canadian beauty ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... from GyencoloGeneTM, the world’s first commercially-available next-generation sequencing laboratory test for bacterial ... of Gynecology and Obstetrics in Vancouver, BC, Canada. , In a ...
(Date:10/13/2015)... ... October 13, 2015 , ... Doulagivers is O'Brien's ... Training and End of Life Doula Training. A Doulagiver is a non-medical ... and emotionally. Based on her #1 International bestselling book Creating Positive Passings ...
(Date:10/12/2015)... ... October 13, 2015 , ... Career Step, ... the release of its new Professional Medical Coding and Billing with Applied PCS ... ICD-10-CM and ICD-10-PCS code sets, earn the Certified Professional Coder (CPC) and Certified ...
Breaking Medicine News(10 mins):
(Date:10/12/2015)... 12, 2015  CME Group,s Center for Innovation ... of Theranos, is the 11 th recipient of the ... revolutionary blood diagnostics company, Theranos , to change health ... a new era of preventive care. CME Group will present ... Conference in Naples, Florida , on ...
(Date:10/12/2015)... 12, 2015 --> ... Review, H2 2015 market research report provides data ... by identifying new targets and MOAs to produce ... . --> . ... across 62 pages, analyzing 6 companies, 8 drug ...
(Date:10/12/2015)... October 12, 2015 --> ... on the global vital signs monitoring devices market in its ... Analysis and Opportunity Assessment 2015-2025." The global vital signs monitoring ... of 9.5% and 9.2% in terms of value and volume, ... FMI offers major insights in detail in this report. ...
Breaking Medicine Technology: